Increased biogenic catecholamine and metabolite levels in two patients with malignant catatonia
Koichi Nisijima Department of Psychiatry, Jichi Medical University, Tochigi, Japan Abstract: The pathophysiology of malignant catatonia, a rare life-threatening psychiatric syndrome, has not yet been elucidated. This paper reports on two patients with malignant catatonia who showed elevated urinary...
Guardado en:
Autor principal: | |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/71725685f61f4fa38b9f6acb6b9880d9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:71725685f61f4fa38b9f6acb6b9880d9 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:71725685f61f4fa38b9f6acb6b9880d92021-12-02T00:06:32ZIncreased biogenic catecholamine and metabolite levels in two patients with malignant catatonia1176-63281178-2021https://doaj.org/article/71725685f61f4fa38b9f6acb6b9880d92013-08-01T00:00:00Zhttp://www.dovepress.com/increased-biogenic-catecholamine-and-metabolite-levels-in-two-patients-a14001https://doaj.org/toc/1176-6328https://doaj.org/toc/1178-2021Koichi Nisijima Department of Psychiatry, Jichi Medical University, Tochigi, Japan Abstract: The pathophysiology of malignant catatonia, a rare life-threatening psychiatric syndrome, has not yet been elucidated. This paper reports on two patients with malignant catatonia who showed elevated urinary or plasma catecholamine levels. Patient 1 had high catecholamine and metabolite levels in a 24-hour urine sample, and patient 2 had elevated plasma catecholamine levels. These findings indicate the presence of peripheral sympathetic nervous system hyperactivity in malignant catatonia. Symptoms of autonomic dysfunction, including tachycardia, labile blood pressure, and diaphoresis, are typical features of malignant catatonia and may be related to the increased levels of biogenic amines in these cases. Although the findings in the present study cannot entirely explain the pathophysiology of malignant catatonia, they do indicate that hyperactivity of the sympathetic nervous system may be involved in the pathology of this condition. Keywords: malignant catatonia, catecholamine levels, neuroleptic malignant syndromeNisijima KDove Medical PressarticleNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2013, Iss default, Pp 1171-1174 (2013) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 |
spellingShingle |
Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Nisijima K Increased biogenic catecholamine and metabolite levels in two patients with malignant catatonia |
description |
Koichi Nisijima Department of Psychiatry, Jichi Medical University, Tochigi, Japan Abstract: The pathophysiology of malignant catatonia, a rare life-threatening psychiatric syndrome, has not yet been elucidated. This paper reports on two patients with malignant catatonia who showed elevated urinary or plasma catecholamine levels. Patient 1 had high catecholamine and metabolite levels in a 24-hour urine sample, and patient 2 had elevated plasma catecholamine levels. These findings indicate the presence of peripheral sympathetic nervous system hyperactivity in malignant catatonia. Symptoms of autonomic dysfunction, including tachycardia, labile blood pressure, and diaphoresis, are typical features of malignant catatonia and may be related to the increased levels of biogenic amines in these cases. Although the findings in the present study cannot entirely explain the pathophysiology of malignant catatonia, they do indicate that hyperactivity of the sympathetic nervous system may be involved in the pathology of this condition. Keywords: malignant catatonia, catecholamine levels, neuroleptic malignant syndrome |
format |
article |
author |
Nisijima K |
author_facet |
Nisijima K |
author_sort |
Nisijima K |
title |
Increased biogenic catecholamine and metabolite levels in two patients with malignant catatonia |
title_short |
Increased biogenic catecholamine and metabolite levels in two patients with malignant catatonia |
title_full |
Increased biogenic catecholamine and metabolite levels in two patients with malignant catatonia |
title_fullStr |
Increased biogenic catecholamine and metabolite levels in two patients with malignant catatonia |
title_full_unstemmed |
Increased biogenic catecholamine and metabolite levels in two patients with malignant catatonia |
title_sort |
increased biogenic catecholamine and metabolite levels in two patients with malignant catatonia |
publisher |
Dove Medical Press |
publishDate |
2013 |
url |
https://doaj.org/article/71725685f61f4fa38b9f6acb6b9880d9 |
work_keys_str_mv |
AT nisijimak increasedbiogeniccatecholamineandmetabolitelevelsintwopatientswithmalignantcatatonia |
_version_ |
1718403934942396416 |